Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47 participants
INTERVENTIONAL
2021-09-15
2023-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peripheral Choroidal Layer Response
NCT05132140
Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control
NCT04080128
Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms
NCT02851654
Application and Clinical Evaluation of Longitudinal Chromatic Aberration Technique in Ophthalmology
NCT06449976
Pilocarpine and Brimonidine in Patients With Monofocal Lenses
NCT03825081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
50% brightness group
Participants will be using a computer screen reducing screen brightness 50%.
Brightness
Changing the colors or brightness on the device (computer screen) for one month
Light App group
Participants in this group will use a modulating computer screen tone with flux or night shift app.
Brightness
Changing the colors or brightness on the device (computer screen) for one month
Control group
Participants in this group will be a control with no change in screen features
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brightness
Changing the colors or brightness on the device (computer screen) for one month
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Adult person without intact vision
* Adult who does not use computer screens
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leela Raju, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Langone Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-00472
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.